Medicinal chemistry

Medicinal Chemistry

Medicinal Chemistry is a research theme within the Monash Institute of Pharmaceutical Sciences (MIPS).

See the latest news

Venom power: Scientists receive funding to develop novel drug for multiple sclerosis

Research into a modified toxin from the venom of a scorpion has led a team of Monash University scientists a step closer to preclinical trials of a new drug candidate for multiple sclerosis (MS).

MIPS medicinal chemistry platform progresses partnered research programs via the Therapeutic Innovation Australia pipeline initiative

The Australian Translational Medicinal Chemistry Facility (ATMCF) and partners have received over $500,000 in funding for five different projects as part of the Therapeutic Innovation Australia (TIA)

MIPS researchers PIK out a new drug target to reduce heart attacks

Researchers from Monash University’s Institute of Pharmaceutical Sciences (MIPS) together with other Monash and international collaborators have discovered a new target for drugs that could potentially prevent heart attacks and strokes by

Prof Jonathan Baell collaborates with PMCC on Nature publication

Professor Jonathan Baell from MIPS has collaborated with researchers from the Peter MacCallum Cancer Centre to discover a new way to target acute myeloid leukaemia (AML) at its source - a discovery that could yield a more effective

MIPS maintains top score in 2018 ERA rankings

The Monash Institute of Pharmaceutical Sciences has again received excellent results in the latest Excellence in Research for Australia (ERA) rankings.

Representatives of the three PharmAlliance partners: (L-R) Dr Andreia Bruno (Monash), Dr Oksana Pyzik (UCL) and Dr David Steeb (UNC)

PharmAlliance meets at Monash University

PharmAlliance, the research, professional practice and education partnership between the Schools of Pharmacy at Monash University, University College London (UCL) and the University of North Carolina at Chapel Hill (UNC), has held its

Faculty success in major Commonwealth grant programs

The Monash Faculty of Pharmacy and Pharmaceutical Sciences has been awarded nearly $20 million dollars in research funding in the recent rounds of grants announced by the National Health and Medical Research Council (“NHMRC”) and the

Monash scientists gain multimillion-dollar NIH grant for ‘superbug’ drug discovery program

August 2017

A world-leading team, led by Professor Jian Li from the Monash Biomedicine Discovery Institute (BDI), has been awarded a multi-million dollar grant

Monash research sparks major change in editorial policy

May 2017

Monash University drug discovery research has led to a change in editorial policy of the world’s largest scientific society, in a move that could save government and industry millions of dollars a year in